Warburg Pincus and Eastgate Group Joint Venture Completes Shinagawa Seaside Acquisition
Deal News | Apr 03, 2025 | Warburg Pincus

Warburg Pincus and Eastgate Group have announced the acquisition of the Shinagawa Seaside West Tower by their joint venture, marking the third transaction under their collaboration formed in 2023. This joint venture, initiated to address the significant undersupply of life sciences and R&D real estate in Japan, now manages over 1 million square feet of gross floor area and boasts over $300 million in assets under management. The acquisition includes high-quality assets in Tokyo and Yokohama, strategically located to cater to life sciences, hi-tech, and manufacturing industries. The Shinagawa Seaside West Tower provides over 410,000 square feet of state-of-the-art R&D space capable of supporting both dry and wet labs. Warburg Pincus and Eastgate Group emphasize the growing demand in Japan for specialized real estate in the life sciences sector, driven by trends like the aging population and healthcare market growth. Their combined experience and resources position them to capitalize on this significant opportunity, providing long-term value for tenants and investors alike.
Sectors
- Real Estate Investment
- Life Sciences and R&D Real Estate
Geography
- Japan – The entire acquisition and focus of the joint venture is centered on key cities in Japan, such as Tokyo and Yokohama, catering specifically to local market demands.
- Asia – Warburg Pincus's broader investment strategy includes significant real estate activities across Asia, making it relevant to the geographical context of the investment.
Industry
- Real Estate Investment – The article focuses on the real estate investments undertaken by Warburg Pincus and Eastgate Group in Japan, particularly in acquiring properties for life sciences and R&D.
- Life Sciences and R&D Real Estate – The acquisition of specialized properties catering to the life sciences and R&D sectors highlights the demand and strategic focus on these industries within the Japanese market.
Financials
- US$300 million – The total assets under management by the joint venture after the latest acquisition.
Participants
Name | Role | Type | Description |
---|---|---|---|
Warburg Pincus | Investor, Joint Venture Partner | Company | A leading global private equity firm with extensive investment across various sectors including real estate. |
Eastgate Group | Investor, Joint Venture Partner | Company | One of Japan's largest privately owned real estate investment managers with broad experience in managing R&D real estate. |
Shinagawa Seaside West Tower | Target | Company | An 18-storey commercial building in Tokyo acquired by the joint venture for life sciences and R&D use. |
GRC Yokohama Bay Research Park | Acquired Asset | Company | A mixed-use commercial building in Yokohama acquired by the venture, currently housing various specialist industry tenants. |
GRC Yokohama Science Cube | Acquired Asset | Company | A soon-to-be-renamed facility set for transformation into a cutting-edge R&D and medical facility adjacent to Center Kita Station in Yokohama. |
Takashi Murata | Managing Director, Co-Head of Asia Real Estate | Person | Overseeing Warburg Pincus's real estate activities in Japan and Asia. |
Shozo Sekine | Founder and CEO | Person | Leads Eastgate Group's operations and strategic partnerships in the R&D real estate sector. |